Our early discovery scientist experts have proven backgrounds of successfully meeting and often exceeding time sensitive deliverables for clients, which in turn moves potential leads into medicinal chemistry stages and establishes the ROI barometer. By collaborating together intimately with R&D scientists on the client side, our medicinal chemists can deliver a comprehensive spectrum of chemistry services inclusive of IP guidance to accelerate research programs at every stage in the preclinical process up to IND.
Custom, focused chemical synthesis and fragment-based drug synthesis investigations are at the heart of Aspira Pharma’s discovery chemistry capabilities. We offer a comprehensive medicinal chemistry platform with proof-of-concept reactions completed at the minimum mgs scale of a desired target. We also has expertise in natural products’ chemical reactions and we are proud of our lasting heritage in running multi-step, linear >10 step syntheses. We offer the following comprehensive services in support of clients’ requirements for target identification and validation:
At Aspira Chemical, we are pleased to offer expertise of both breadth and depth in determining the viability of difficult/low sensitivity analytical assay development for a diverse array of therapeutic compounds ranging from natural products to semi-synthetic medicinal chemistry targets to small peptides to synthetic intermediates. Additionally, we can routinely run analytical development, in support (or as one-offs) of therapeutic API programs, on metabolites and Rx intermediates’ impurities.
Our R&D analytical service teams are equipped with various state-of-the-art instruments, such as LC, LC/MS, UPLC, UV, HPLC, GC/MS, HRMS, SEC, SFC, NMR, XRD, FTIR, etc., wherein we have the capabilities of providing full spectrum analytical support to R&D and early drug development. The streamlined samples that flow through our lab and data management systems enable high productivity and quality services per clients’ selective requirements. We have expertise in the following broad analytical areas:
For more information about our highly integrated, end-to-end drug discovery services, please contact firstname.lastname@example.org.